Earnings Review · 04 November 2026
The print
Results are in but not yet verified against a primary source in our ledger; this review updates the moment the audited figures land. What does not change is our read below.
How the market took it
On 2026-11-03 the shares closed at $483.90, +3.7% against the prior close of $466.84 (opening +2.8% from the prior close). Option volatility implied a normal one-day swing of about ±6.5%, so a +3.7% close was smaller than the market implied. Across the last 25 reports the shares have moved an average of +2.4% over the five sessions after the print, so the +3.7% on the day sits ahead of that average.
Did the flow confirm the move?
Underlying money flow is neutral (21-day Chaikin Money Flow -0.01, five-day price change -12.1%, as of 2026-11-02, desk flow model): no strong accumulation or distribution signature.
Give the business its due
The business itself is genuinely strong: revenue growing about 50%,
net margins near 16%, a narrow competitive moat, backed by a 10%
return on equity.
Levels that matter
At $483.90 the shares sit 27% below the 52-week high of $658.52 and 157% above the low of $188.22 (63% of the way up the range). The 50-day average is $542.28, above the price. The 200-day average is $402.06, below the price.
Max pain at $507.50.
Max pain at $520.00. Max pain at $500.00.
The valuation lens
The shares trade about 25% above our fair-value estimate: priced for things to go right. Fair value lands near $387 against a $483.90 share price, a margin of safety of about -25%. The trailing multiple sits around 144 times earnings, which only makes sense if the growth holds.
The
ethical lens, our differentiator
Screens compliant (both standards agree). A name values-conscious investors can weigh on the merits.
The verdict for a values-conscious investor
It clears the screen; size it to your own risk and conviction. One quarter, strong or soft, does not decide whether a holding is suitable.
This is analysis, not financial advice. Always manage your risk.